Intangible Assets

9 Months Ended

Jun. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangible Assets

At September 30, 2021, goodwill and other intangible assets related to the Diabetes Care business were classified as Noncurrent Assets of Discontinued Operations. For additional information, see Note 2.

Intangible assets consisted of:

	June 30, 2022						September 30, 2021
(Millions of dollars)	Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Amortized intangible assets
Developed technology	$	14,498	$	(5,733)	$	8,764	$	14,399	$	(4,983)	$	9,417
Customer relationships	4,677		(2,085)		2,592		4,653		(1,838)		2,815
Product rights	107		(78)		29		123		(83)		40
Trademarks	408		(151)		257		409		(137)		271
Patents and other	542		(344)		198		523		(339)		184
Amortized intangible assets	$	20,231	$	(8,391)	$	11,840	$	20,106	$	(7,381)	$	12,726
Unamortized intangible assets
Acquired in-process research and development	$	44					$	44
Trademarks	2						2
Unamortized intangible assets	$	46					$	46

Intangible amortization expense for the three months ended June 30, 2022 and 2021 was $357 million and $351 million, respectively. Intangible amortization expense for the nine months ended June 30, 2022 and 2021 was $1.064 billion and $1.049 billion, respectively.

The following is a reconciliation of goodwill by business segment:

(Millions of dollars)	Medical		Life Sciences		Interventional		Total
Goodwill as of September 30, 2021	$	10,240	$	836	$	12,810	$	23,886
Acquisitions (a)	—		71		205		276
Purchase price allocation adjustments	—		(1)		(2)		(3)
Currency translation	(81)		(11)		(98)		(191)
Goodwill as of June 30, 2022	$	10,158	$	895	$	12,915	$	23,968

(a)Represents goodwill recognized relative to certain acquisitions which were not material individually or in the aggregate.